NanoString Investor Relations Material
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics. The company offers scanning probe microarrays for a broad range of applications in various disciplines within the life sciences including genomics, epigenomics, virology, immunology, and medical diagnostics for DNA sequencing and RNA analysis. It also provides technology for microRNA (miRNA) detection offering comprehensive capabilities that support discovery to diagnostic screening; as well as discovery stage to commercialization offerings. In addition, the company offers a portfolio of reagents which are designed to work with its Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) solution or isothermal amplification products to perform cell-based investigations into disease pathogenesis or drug development applications. The company has strategic collaboration agreements with pharmaceutical companies, academic institutions, and clinical research organizations to develop novel methodologies for biological analysis and therapeutic discovery.
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
🇺🇸 United States